HPRT1 activity loss is associated with resistance to thiopurine in ALL
Metrics: PDF 470 views | HTML 1028 views | ?
Fan Yang1,2,3,*, Houshun Fang2,3,*, Dan Wang2,3,*, Yao Chen2,3, Yonggong Zhai1, Bin-Bing S. Zhou2,3,4 and Hui Li2,3,4
1Beijing Key Laboratory of Gene Resource and Molecular Development, College of Life Sciences, Beijing Normal University, Beijing, China
2Key Laboratory of Pediatric Hematology and Oncology Ministry of Health, Department of Hematology and Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Pediatric Translational Medicine Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Department of Pharmacology and Chemical Biology, School of Basic Medicine and Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China
*These authors contributed equally to this work
Hui Li, email: email@example.com
Bin-Bing S. Zhou, email: firstname.lastname@example.org
Keywords: thiopurine; leukemia; drug resistance; HPRT1 mutation; purine metabolism
Received: August 02, 2017 Accepted: December 03, 2017 Published: December 19, 2017
Acute lymphoblastic leukemia (ALL) is an aggressive hematological tumor resulting from the malignant transformation of lymphoid progenitors. Thiopurine is a widely used drug in the maintaining treatment of ALL. After a period of chemotherapy, 20% of pediatric patients and over 50% of adult patients will relapse. To investigate the mechanisms of drug resistance in vitro, we established the thiopurine resistant cell lines Reh-6MPR (6-MP Resistant cell) and Reh-6TGR (6-TG Resistant cell) by stepwise selection of the ALL cell line Reh. Cell viability assay revealed that 6MPR and 6TGR cells were almost 1000-fold more resistant to thiopurine comparing with the control Reh cells, and thiopurine conversion was significantly impaired in the resistant cells. Mechanistically, a same novel hypoxanthine phosphoribosyl transferase 1 (HPRT1) mutation c.495_496insA (p.V165fs) was found by whole exome sequencing in both resistant cells. The HPRT1 mutation dramaticly decreased the production of [13C5,15N4]-IMP from [13C5,15N4]-hypoxanthine (HX), showed a loss-of-funciton mechanism. Notably, re-expression the wildtype HPRT1 in Reh-6MPR cell can reverse the drug resistance and thiopurine conversion in Reh-6MPR cells. These results highlight the importance of HPRT1’s activity in thiopurine resistance.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.